Featured Research

from universities, journals, and other organizations

Driving while distracted is a primary-care issue, physician says; Talking or texting behind the wheel is roughly equivalent to driving drunk

Date:
June 13, 2010
Source:
Beth Israel Deaconess Medical Center
Summary:
It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, a primary-care physician suggests.

A recent study suggested texting while driving raised the risk of collision by a factor of 23.
Credit: iStockphoto

It's time for physicians to talk to patients about driving while distracted, a problem that has risen to the rough equivalence of drunken driving thanks to the proliferation of phones that allow drivers to talk and text, Amy Ship, MD, a primary care physician at Beth Israel Deaconess Medical Center suggests.

Writing in the June 10 issue of the New England Journal of Medicine, Ship notes physicians routinely ask patients about habits associated with potential harm like the use of helmets, seatbelts, cigarettes, condoms, drugs and alcohol. And with data showing 28 percent of all accidents in the United States are caused by drivers talking on cell phones or texting, it's time to step into this issue too.

"When a doctor raises an issue while providing overall preventive care, the message is different from that conveyed by a public service announcement nestled between ads for chips and beer or a printed warning on a product box," she writes. "It's time for us to ask patients about driving and distraction."

While the absolute increase in the risk of collision attributable to distracted drivers is hard to assess, Ship says one study showed talking and driving posed a four time greater risk than undistracted driving. A second study suggested texting raised the risk of collision by a factor of 23.

"More than 275 million Americans own cell phones and 81 percent of them talk on those phones while driving. The adverse consequences have reached epidemic proportions."

Ship acknowledges that while there is little solid evidence that screening questions about drugs, alcohol smoking and other risks have any benefit, that fact has never stopped clinicians from making inquiries.

"As our technology evolves, our questions must be updated in keeping with the risks," she says.

In her own practice, where Ship queries all her patients annually on this issue, she occasionally encounters patients who wonder why talking on the phone, even with a hands-free device, is more dangerous than talking to a passenger.

"First is the obvious risk associated with trying to maneuver a phone, but cognitive studies have also shown that we are unable to multitask and that neurons are diverted differently depending on whether we are talking on a phone or talking to a passenger," she says.

But for the ultimate skeptic, Ship has a ready response:

"How would you feel if the surgeon removing your appendix talked on the phone -- hands-free of course -- while operating?"

Ultimately, Ship says, clinicians have an obligation to adapt to societal changes and update their model of preventive care.

"Primary care doctors are uniquely positioned to teach and influence patients: we should not squander that power. A question about driving and distraction is as central to the preventive care we provide as the other questions we ask. Not to ask -- and not to educate our patients and reduce their risk -- is to place in harm's way those we hope to heal."

Ship is a physician in the Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center and an Assistant professor of Medicine at Harvard Medical School. No potential conflicts of interest relevant to this article were reported.


Story Source:

The above story is based on materials provided by Beth Israel Deaconess Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Amy N. Ship. The Most Primary of Care %u2014 Talking about Driving and Distraction. New England Journal of Medicine, 2010; 362 (23): 2145-2147 [link]

Cite This Page:

Beth Israel Deaconess Medical Center. "Driving while distracted is a primary-care issue, physician says; Talking or texting behind the wheel is roughly equivalent to driving drunk." ScienceDaily. ScienceDaily, 13 June 2010. <www.sciencedaily.com/releases/2010/06/100609171748.htm>.
Beth Israel Deaconess Medical Center. (2010, June 13). Driving while distracted is a primary-care issue, physician says; Talking or texting behind the wheel is roughly equivalent to driving drunk. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/06/100609171748.htm
Beth Israel Deaconess Medical Center. "Driving while distracted is a primary-care issue, physician says; Talking or texting behind the wheel is roughly equivalent to driving drunk." ScienceDaily. www.sciencedaily.com/releases/2010/06/100609171748.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins